Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
CM-336 BCMA/CD3 bispecific antibody
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AL Amyloidosis
1 trial -
CMV-VST
Chongqing Precision Biotech Co., Ltd
Cytomegalovirus Viremia
1 trial -
CSB drum dried + Ξ±-amylase
United Therapeutics Europe Ltd
Malnutrition
1 trial -
CSB14
United Therapeutics Europe Ltd
Child Malnutrition
1 trial -
CYP2C19 genotype testing
Beijing Anzhen Hospital
Angina, Stable
1 trial -
Ca/Vit D
United Therapeutics Europe Ltd
Bone Health
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
Caffeine
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Calcium Carbonate 1500 Mg with Vitamin D
Hospital Authority, Hong Kong
Thyroid Neoplasm
1 trial -
Cambridge Weight Plan
United Therapeutics Europe Ltd
Diabetes
1 trial -
Canagliflozin
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus With Complication
1 trial -
Cannabis (30% THC Concentrate)
BRIGHT MINDS BIOSCIENCES INC.
THC
1 trial -
Carbon Nanoparticle Suspension Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Carbon ion radiotherapy
Shanghai Proton and Heavy Ion Center
Pancreatic Cancer Non-resectable
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Cholangiocarcinoma
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety Issues
1 trial -
Celebrex
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Celecoxib
The First People's Hospital of Lianyungang
Low Back Pain
1 trial -
Celecoxib 400mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peutz-Jeghers Syndrome
1 trial -
Chinese herbal medicine
The First People's Hospital of Lianyungang
Acute on Chronic Liver Failure
1 trial -
Chinese herbs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression
1 trial -
Chronotropic Incompetence Diagnostic Algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources